A double-blind randomized trial of adefo
β
MinDe Zeng; YiMin Mao; GuangBi Yao; Hao Wang; JinLin Hou; YaoZong Wang; Beulah N
π
Article
π
2006
π
John Wiley and Sons
π
English
β 279 KB
π 1 views
Four hundred and eighty Chinese subjects with hepatitis B e antigen (HBeAg)-positive chronic hepatitis B (CHB) were enrolled in a multicenter, double-blind, randomized, placebo-controlled study of adefovir dipivoxil (ADV) 10 mg once daily. There was a significant difference in reduction of serum hep